245 results on '"Jungbauer, Carsten"'
Search Results
2. Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD
3. The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
4. Abstract 15446: Impact of Patient Demographics on Optimal Beta-Blocker Use After New-Onset Heart Failure: Analysis of the HF-OPT Study (Heart Failure Optimization Study)
5. Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
6. Cardiac iron overload promotes cardiac injury in patients with severe COVID-19
7. Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
8. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial
9. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19
10. Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness
11. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
12. Alterations of the renin angiotensin system in human end-stage heart failure before and after mechanical cardiac unloading by LVAD support
13. Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated?
14. Achieving Guideline-Directed Heart Rate ControlEarly Posthospitalization
15. Restoration of von Willebrand factor after transcatheter aortic valve replacement—A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
16. RNA-expression of adrenomedullin is increased in patients with severe COVID-19
17. Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19
18. Cardiac unloading by LVAD support differentially influences components of the cGMP–PKG signaling pathway in ischemic and dilated cardiomyopathy
19. A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode
20. Urinary N-Terminal Pro-Brain Natriuretic Peptide Predicts Acute Kidney Injury and Severe Disease in COVID-19
21. Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
22. A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode
23. Early-BYRD: alternative early pacing and defibrillation lead replacement avoiding venous puncture
24. Impact of coronavirus disease (COVID-19) pandemic on physical activity of patients with cardiac implantable electronic devices—A remote monitoring study
25. Effects of Reduced Kidney Function Because of Living Kidney Donation on Left Ventricular Mass
26. Proteomic Profiling Implies Mitochondrial Dysfunction in Tachycardia-Induced Heart Failure
27. NAG: potential cardiorenal biomarker indicates progression of chronic kidney disease in implantable cardioverter defibrillator patients, contrary to KIM-1
28. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial
29. Evaluation of a multimarker panel in chronic heart failure: a 10-year follow-up
30. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure
31. Combination of high frequency oscillatory ventilation and interventional lung assist in severe acute respiratory distress syndrome
32. Secondary prevention implantable cardioverter-defibrillator (ICD) therapy: value in octogenarians
33. Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention
34. Heart Failure with Recovered Ejection Fraction (HFrecEF): a new entity with improved cardiac outcome
35. Cardiac Fibrosis Is a Risk Factor for Severe COVID-19
36. Cardiac iron overload promotes cardiac injury in patients with severe COVID-19
37. The low acute effectiveness of a high-power short duration radiofrequency current application technique in pulmonary vein isolation for atrial fibrillation
38. N-acetyl-ß-D-glucosaminidase is predictive of mortality in chronic heart failure: a 10-year follow-up
39. Unmasking the dormant pulmonary vein conduction with adenosine administration after pulmonary vein isolation with laser energy
40. Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices
41. Comparison of PV signal quality using a novel circular mapping and ablation catheter versus a standard circular mapping catheter
42. Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure
43. A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support
44. Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation
45. Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
46. Novel Implantable Cardioverter Defibrillator Programming With High Rate Cut-Off, Long Detection Intervals and Multiple Anti-Tachycardia Pacing Reduces Mortality
47. Equal performance of novel N-terminal proBNP (Cardiac proBNP®) and established BNP (Triage BNP®) point-of-care tests
48. Assessment of Association Between Venous Occlusion and Infection of Cardiac Implantable Electronic Devices.
49. NAG: potential cardiorenal biomarker indicates the progression of chronic kidney disease in implantable cardioverter defibrillator patients, contrary to KIM-1.
50. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.